These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 34216102)
21. Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19? Alvarado-Vasquez N Med Hypotheses; 2021 Jan; 146():110378. PubMed ID: 33189452 [TBL] [Abstract][Full Text] [Related]
22. COVID-19 and Type 2 Diabetes Mellitus: HCQ may be the Holy Grail. Pal R; Bhasin MK; Bhadada SK Infect Disord Drug Targets; 2021; 21(5):e270421186842. PubMed ID: 33050869 [TBL] [Abstract][Full Text] [Related]
23. COVID-19 and Diabetes: will Novel Drugs for Diabetes Help in COVID-19? Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Dubey R; Prabhakar PK; Batiha GE Curr Mol Pharmacol; 2023; 16(4):494-506. PubMed ID: 36089790 [TBL] [Abstract][Full Text] [Related]
24. Viral infection and host immune response in diabetes. Joshi G; Das A; Verma G; Guchhait P IUBMB Life; 2024 May; 76(5):242-266. PubMed ID: 38063433 [TBL] [Abstract][Full Text] [Related]
25. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane? Jagat J M; Kalyan K G; Subir R Diabetes Metab Syndr; 2020; 14(5):829-831. PubMed ID: 32540737 [TBL] [Abstract][Full Text] [Related]
26. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report. Jornayvaz FR; Assouline B; Pugin J; Gariani K BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762 [TBL] [Abstract][Full Text] [Related]
27. Association between newly diagnosed hyperglycemia/diabetes mellitus, atherogenic index of plasma and obesity in post-COVID-19 syndrome patients. Emiroglu C; Dicle M; Yesiloglu C; Gorpelioglu S; Aypak C Endocrine; 2024 May; 84(2):470-480. PubMed ID: 38001321 [TBL] [Abstract][Full Text] [Related]
28. Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A single-center study. Hardy YO; Libhaber E; Ofori E; Amenuke DAY; Kontoh SA; Dankwah JA; Larsen-Reindorf R; Otu-Ansah C; Hutton-Mensah K; Dadson E; Adamu S; Akyerekoh K; Sarfo FS; Nkum B Endocrinol Diabetes Metab; 2023 Jan; 6(1):e391. PubMed ID: 36426913 [TBL] [Abstract][Full Text] [Related]
29. The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID-19. Xu Z; Wang Z; Wang S; Ye Y; Luo D; Wan L; Yu A; Sun L; Tesfaye S; Meng Q; Gao L J Diabetes; 2020 Dec; 12(12):909-918. PubMed ID: 32638507 [TBL] [Abstract][Full Text] [Related]
30. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'. Stefano GB; Kream RM Med Sci Monit; 2020 Nov; 26():e929789. PubMed ID: 33239605 [TBL] [Abstract][Full Text] [Related]
31. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Pal R; Bhadada SK Diabetes Metab Syndr; 2020; 14(4):513-517. PubMed ID: 32388331 [TBL] [Abstract][Full Text] [Related]
32. Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People. Demaret J; Corroyer-Simovic B; Alidjinou EK; Goffard A; Trauet J; Miczek S; Vuotto F; Dendooven A; Huvent-Grelle D; Podvin J; Dreuil D; Faure K; Deplanque D; Bocket L; Duhamel A; Labreuche J; Sobaszek A; Hisbergues M; Puisieux F; Labalette M; Lefèvre G Front Immunol; 2021; 12():778679. PubMed ID: 34868051 [TBL] [Abstract][Full Text] [Related]
33. Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19. Zhao G; Xu Y; Li J; Cui X; Tan X; Zhang H; Dang L Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350432 [TBL] [Abstract][Full Text] [Related]
34. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study. Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952 [TBL] [Abstract][Full Text] [Related]
36. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus. Jing Liang J; Liu J; Chen Y; Ye B; Li N; Wang X; Tang M; Shao J Diabetes Res Clin Pract; 2020 Sep; 167():108351. PubMed ID: 32711001 [TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444 [TBL] [Abstract][Full Text] [Related]
38. Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review. Lisco G; De Tullio A; Giagulli VA; Guastamacchia E; De Pergola G; Triggiani V Endocrine; 2020 Dec; 70(3):441-453. PubMed ID: 32779091 [TBL] [Abstract][Full Text] [Related]
39. Pediatric diabetes mellitus hospitalizations and COVID-19 pandemic response measures. Shimony H; Miller L; Reich P; Banull NR; Burch M; Bryan M; María Arbeláez A Diabetes Res Clin Pract; 2024 Jan; 207():111060. PubMed ID: 38110121 [TBL] [Abstract][Full Text] [Related]